Affiliated Cancer Hospital of Harbin Medical University

Harbin, Heilongjiang 150081

0 studies enrolling now · 2 studies all time

What they study most

Small Cell Lung Cancer (SCLC)

Studies at this site

• A Phase 2, Open-label, Randomized, Multicenter Study of Tarlatamab Dosing Regimens in Subjects With SCLC — Running, not enrolling
• Study Comparing Tarlatamab With Standard of Care Chemotherapy in Relapsed Small Cell Lung Cancer — Running, not enrolling